Related Experiment Video
Updated: Feb 1, 2026

Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes
Published on: February 22, 2017
Targeting the DNA-PK complex: Its rationale use in cancer and HIV-1 infection
C Schwartz1, O Rohr1, C Wallet1
1University of Strasbourg, EA7292, DHPI, IUT Louis Pasteur, Schiltigheim, France.
Abstract:
The DNA-PK complex is the major component of the predominant mechanism of DSB repair in humans. In addition, this complex is involved in many other processes such as DNA recombination, genome maintenance, apoptosis and transcription regulation. Several studies have linked the decrease of the DNA-PK activity with cancer initiation, due to defects in the repair. On another hand, higher DNA-PK expression and activity have been observed in various other tumor cells and have been linked with a decrease of the efficiency of anti-tumor drugs. It has also been shown that DNA-PK is critical for the integration of the HIV-1 DNA into the cell host genome and promotes replication and transcription of the virus. Targeting this complex makes therefore sense to treat these two pathologies. However, according to the status of HIV-1 replication (active versus latent replication) or to the tumor grade cells (initiation versus metastasis), the way to target this DNA-PK complex might be rather different. In this review, we discuss the importance of DNA-PK complex in two major pathologies i.e. HIV-1 infection and cancer, and the rationale use of therapies aiming to target this complex.
Insights
The DNA-PK complex is crucial for DNA repair and impacts cancer and HIV-1. Targeting DNA-PK offers therapeutic potential for both diseases, but strategies must adapt to disease stage.
Area of Science:
- Molecular Biology
- Genetics
- Virology
Background:
- The DNA-PK complex is central to DNA double-strand break (DSB) repair in humans.
- It also regulates DNA recombination, genome stability, apoptosis, and transcription.
- Dysfunctional DNA-PK activity is implicated in cancer initiation and progression, and HIV-1 replication.
Purpose of the Study:
- To review the dual role of the DNA-PK complex in cancer and HIV-1 infection.
- To explore the rationale for targeting DNA-PK in these pathologies.
- To discuss context-dependent therapeutic strategies for DNA-PK inhibition.
Main Methods:
- Literature review of studies on DNA-PK function in cancer and HIV-1.
- Analysis of the link between DNA-PK activity and disease progression.
- Evaluation of therapeutic strategies targeting DNA-PK.
Main Results:
- Decreased DNA-PK activity is linked to cancer initiation due to repair defects.
- Elevated DNA-PK in tumors can reduce anti-cancer drug efficacy.
- DNA-PK is essential for HIV-1 DNA integration and viral replication.
Conclusions:
- Targeting the DNA-PK complex presents a viable therapeutic approach for both cancer and HIV-1.
- Therapeutic strategies must be tailored based on disease status, such as cancer grade or HIV-1 replication.
- Further research is needed to optimize context-specific DNA-PK inhibition therapies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
From DNA to Protein
Overview of DNA Repair
Chemically...

